SILENCE THERAPEUTICS PLC-ADR (SLN)

US82686Q1013 - ADR

21.99  +0.69 (+3.24%)

After market: 21.99 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
N/AN/AN/A15.779M
EBITDA
YoY % growth
N/AN/AN/A-75.086M
EBIT
YoY % growth
N/AN/AN/A-80.063M
Operating Margin
N/AN/AN/A-507.40%
EPS
YoY % growth
N/AN/AN/A-0.36

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth		 -0.23
-66.42%		-0.22-0.01-2.96%
Q4 2020
Q2Q % growth		 -0.26 -0.21-0.05-22.41%
Q2 2020
Q2Q % growth		 -0.14 -0.220.0938.71%
Q2 2015
Q2Q % growth		 -0.07
38.26%		-0.070.002.91%
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth		 4.765M 18.981M-14.216M-74.90%
Q2 2021
Q2Q % growth		 5.845M
410.03%		5.845M∞%
Q4 2020
Q2Q % growth		 4.333M
1,675.82%		2.472M1.861M75.28%
Q2 2020
Q2Q % growth		 1.146M
∞%		1.854M-708K-38.19%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A